ARCHIVES

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

This article is from The Cancer Letter archive.

Vol. 02 No. 06 | February 6, 1976

Download PDF Visit The Full Archive

Related Articles

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

AACR Receives Record Number of Abstracts

January 27, 1989

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008